Spectrascience Financial Statements From 2010 to 2026

SCIEDelisted Stock  USD 1.42  0.00  0.00%   
Spectrascience New's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Spectrascience New's valuation are provided below:
Spectrascience New does not presently have any fundamental trend indicators for analysis.
Check Spectrascience New financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Spectrascience New's main balance sheet or income statement drivers, such as , as well as many indicators such as . Spectrascience financial statements analysis is a perfect complement when working with Spectrascience New Valuation or Volatility modules.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Spectrascience New Company Return On Asset Analysis

Spectrascience New's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Spectrascience New Return On Asset

    
  -0.92  
Most of Spectrascience New's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Spectrascience New is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, Spectrascience New has a Return On Asset of -0.9247. This is 89.43% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.

Spectrascience New Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Spectrascience New's current stock value. Our valuation model uses many indicators to compare Spectrascience New value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Spectrascience New competition to find correlations between indicators driving Spectrascience New's intrinsic value. More Info.
Spectrascience New is rated below average in return on asset category among its peers. It is rated fifth in current valuation category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Spectrascience New by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

About Spectrascience New Financial Statements

Spectrascience New stakeholders use historical fundamental indicators, such as Spectrascience New's revenue or net income, to determine how well the company is positioned to perform in the future. Although Spectrascience New investors may analyze each financial statement separately, they are all interrelated. For example, changes in Spectrascience New's assets and liabilities are reflected in the revenues and expenses on Spectrascience New's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Spectrascience New. Please read more on our technical analysis and fundamental analysis pages.
SpectraScience, Inc. develops and markets a technology platform to instantly determine whether a tissue is normal, pre-cancerous, or cancerous without the need for a physical biopsy in the United States, Europe, and internationally. SpectraScience, Inc. was founded in 1983 and is based in San Diego, California. Spectrascience operates under Medical Appliances Equipment classification in the United States and is traded on OTC Exchange. It employs 5 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Spectrascience Stock

If you are still planning to invest in Spectrascience New check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Spectrascience New's history and understand the potential risks before investing.
Global Correlations
Find global opportunities by holding instruments from different markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Transaction History
View history of all your transactions and understand their impact on performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments